Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.

Anthony J Swerdlow, Rosie Cooke, Kerstin Albertsson-Wikland, Birgit Borgström, Gary Butler, Stefano Cianfarani, Peter Clayton, Joël Coste, Annalisa Deodati, Emmanuel Ecosse, Ruth Gausche, Claudio Giacomozzi, Wieland Kiess, Anita C S Hokken-Koelega, Claudia E Kuehni, Fabienne Landier, Marc Maes, Primus-E Mullis, Roland Pfaffle, Lars SävendahlGrit Sommer, Muriel Thomas, Sally Tollerfield, Gladys R J Zandwijken, Jean-Claude Carel

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.'. Together they form a unique fingerprint.

    Biochemistry, Genetics and Molecular Biology

    Pharmacology, Toxicology and Pharmaceutical Science